Evaluation of the Effect of HFMT in Promoting Donor-site Wound Healing
Wound Heal
About this trial
This is an interventional treatment trial for Wound Heal focused on measuring hair transplantation
Eligibility Criteria
Inclusion Criteria: Patients aged 18-60 years who underwent FUE autologous hair transplantation. The patient's liver and kidney function were normal, and the serum protein level before surgery was normal. Exclusion Criteria: Patients with a history of smoking. Those suffering from diseases that affect wound healing, such as diabetes or hyperglycemia. Those with abnormal blood sugar. Abnormal cardiopulmonary function. There are foci of infection in or near the surgical area. Scar hyperplasia or scar constitution. Those with a history of neuralgia. The patient took immunosuppressants, cytostatics, and hormonal anticoagulants before surgery and antibiotics.
Sites / Locations
- Nanfang Hospital of Southern Medical University
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
HFMT treated
Mupirocin treated
The experimental group will receive treatment with HFMT ointment prepared in a homogenized mixture, applied once immediately after surgery to the treatment area.
The control group will receive treatment with Mupirocin applied once immediately after surgery to the control area.